logo

Equillium Inc. (EQ)



Trade EQ now with
  Date
  Headline
11/6/2020 8:39:02 AM Equillium Announces Positive Interim Data From Third Cohort Of Phase 1b Study Of Itolizumab
3/26/2020 4:12:31 PM Equillium Q4 Loss/share $0.44 Vs. Loss $0.31 Year Ago
12/12/2019 7:15:04 AM Equillium And Biocon Expand Collaboration And License Agreement For Itolizumab